Skip to main content

Table 1 Reported cases of colon cancer accompanied with tumor thrombus in the superior mesenteric veins

From: Treatment of tumor thrombus in the superior mesenteric vein due to advanced colon cancer with complete surgical resection and chemotherapy: a case report

No.

First author

Year

Age/sex

Location of primary lesion

Histological type

ly/v

Complete resection

Adjuvant chemotherapy

Recurrence

Prognosis

1

Kawashima [14]

2007

78/F

A

Poorly differentiated adenocarcinoma

ly3/v3

Done

5-FU/LV

Liver(4 M)

Dead(5 M)

2

Kanzaki [15]

2009

68/M

T

Moderately differentiated adenocarcinoma

ly2/v3

Done

FOLFOX4, UFT/LV

(–)

Alive(24 M)

3

Yamagami [16]

2009

66/F

A

Moderately differentiated adenocarcinoma

ly2/v3

Done

FOLFIRI

(–)

Alive(22 M)

4

Kamata [17]

2015

70/F

A

Well-differentiated adenocarcinoma

ly1/v1

Done

FOLFOX4

(–)

Alive(9 M)

5

Tajima [18]

2016

60/F

A

Moderately differentiated adenocarcinoma

ly3/v3

no

(–)

Liver, dissemination

Dead(21 M)

6

Akabane [19]

2018

48/F

A

Moderately differentiated adenocarcinoma

ly0/v2

Done

CapeOx

(–)

Alive(17 M)

7

Kim SE [20]

2019

46/F

A

Poorly differentiated adenocarcinoma

N.D

Done

FOLFIRI + Bev

(–)

Alive(12 M)

8

Greally M [21]

2019

54/F

T

Mucinous adenocarcinoma

N.D

Done

FOLFIRI

(–)

Alive(18 M)

9

Fujii [22]

2020

82/M

A

Moderately differentiated adenocarcinoma

N.D

Done

(–)

Liver (6 M)

Dead(8 M)

10

Our case

 

72/M

T

Moderately differentiated adenocarcinoma

ly1/v1

Done

(–)

(–)

Alive(36 M)

  1. M male, F female, A ascending colon, T transverse colon, 5-FU fluorouracil, LV leucovorin, UFT tegafur–uracil, Bev bevacizumab, FOLFOX oxaliplatin/5-FU/leucovorin, FOLFIRI irinotecan/5-FU/leucovorin, CapeOx capecitabine/oxaliplatin